Metropolitan Hospital, affiliated with NYC Health + Hospitals, has attained national recognition for recording a central line–associated bloodstream infection (CLABSI) rate of zero — a rare accomplishment shared by just 338 hospitals across America. The news was reported in an NYC Newswire press announcement.
The distinction is based on findings from the Centers for Medicare & Medicaid Services (CMS) Healthcare-Associated Infections (HAI) metrics, designed to benchmark infection control and patient safety across the country. The data is submitted via the Centers for Disease Control and Prevention’s National Healthcare Safety Network, which serves as the leading infection tracking network nationwide.
“Metropolitan’s interdisciplinary care teams set a benchmark for patient safety nationally,” said Julian S. John, MPA, CEO, NYC Health + Hospitals/Metropolitan. “Receiving this honor illustrates our driving goal: consistently reliable, patient-centered care in every area of our hospital.”
Collaborative Success in Stopping Infections
Securing a CLABSI rate of zero results from comprehensive, hospital-wide compliance with evidence-based practices, flawless central line placement and care, and rigorous infection control guidelines. Nursing, critical care, infection prevention, and quality management staff cooperate closely, reviewing device need, performing maintenance checks, and championing the use of sterile methods at every step.
From October 2023 to September 2024, CMS HAI data assessed infection rates for all patients—adults, children, newborns, Medicare and non-Medicare—presenting a comparative view of hospital infection rates nationwide.
Dedicated to Continuous Improvement
“Our zero CLABSI rate is evidence of clinical excellence, continuous protocol enhancement, real-time infection surveillance, and multiteam coordination—all key in elevating patient safety,” stated Maria Castaldi, MD, FACS, Chief Quality Officer, Metropolitan Hospital.
“Eliminating central line–associated bloodstream infections attests to the value of strong quality-improvement systems that keep patient safety at our core,” said Anitha Srinivasan, MD, MPH, FACS, Chief Medical Officer.
Christopher G. Wilson, MSN, RN, CNML, CENP, NEA-BC, FACHE, Chief Nursing Officer, commended the direct care providers: “This milestone was achieved thanks to our teams’ skills, ongoing training programs, clinical accuracy, and deep commitment to patient well-being and safety.”
With infectious threats evolving in healthcare today, Metropolitan Hospital’s outstanding CLABSI prevention underscores its pledge to staff education, vigilant monitoring, and process improvement for safer, high-quality patient care.
